Home › Funds › VICTORY CAPITAL MANAGEMENT INC › VRTX

VICTORY CAPITAL MANAGEMENT INC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

VICTORY CAPITAL MANAGEMENT INC reported holding 2,558,047 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.34B, representing 0.76% of its reported portfolio and ranking #16 among its reported holdings. VICTORY CAPITAL MANAGEMENT INC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.56M sh
Reported value held$1.34B
Portfolio Weight0.76%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VICTORY CAPITAL MANAGEMENT INC's VRTX position evolved

VICTORY CAPITAL MANAGEMENT INC first disclosed a stake in VRTX in Q3 2023 at 578,451 shares (US$201.2M). The position peaked in Q4 2025 at 3,356,766 shares, worth US$1.52B. Across 13 filings, VICTORY CAPITAL MANAGEMENT INC increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,558,047 shares valued at US$1.34B — an increase of 384,895 shares quarter over quarter.. Notable position changes include a 633% increase in Q2 2025 (shares fell 12% over the following quarter), a 49% increase in Q4 2025 (shares fell 1% over the following quarter), a 44% trim in Q1 2026 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 578.45K $201.15M New
Q4 2023 435.84K $177.34M Reduce
Q1 2024 407.65K $170.40M Reduce
Q2 2024 325.75K $152.68M Reduce
Q3 2024 310.41K $144.37M Reduce
Q4 2024 305.15K $122.88M Reduce
Q1 2025 293.88K $142.48M Reduce
Q2 2025 2.16M $967.78M Add
Q3 2025 2.25M $787.32M Add
Q4 2025 3.36M $1.52B Add
Q1 2026 1.89M $843.33M Reduce
Q2 2026 2.17M $1.08B Add
Q3 2026 2.56M $1.34B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 31 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has VICTORY CAPITAL MANAGEMENT INC held VRTX?

VICTORY CAPITAL MANAGEMENT INC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is VICTORY CAPITAL MANAGEMENT INC's current position in VRTX?

As of Q3 2026, VICTORY CAPITAL MANAGEMENT INC holds 2.56M shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $1.34B, representing 0.76% of its reported portfolio and ranking #16.

Has VICTORY CAPITAL MANAGEMENT INC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), VICTORY CAPITAL MANAGEMENT INC increased its position in VRTX. The position peaked in Q4 2025 at 3.36M shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.